🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ozlem Calbay

AbbVie (United States)

ORCID: 0000-0003-3809-3700

Biochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer”.

Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer

Signal Transduction and Targeted Therapy(2020)10.1038/s41392-020-0197-8

N/A

0DataRank · unranked

33 citations

Yue Li, Tao Li, Ravi N. Padia, Ozlem Calbay, Lingtao Jin +3 more

ASC/inflammasome-independent pyroptosis in ovarian cancer cells through translational augmentation of caspase-1

iScience(2023)10.1016/j.isci.2023.108408

N/A

0DataRank · unranked

22 citations

Ravi N. Padia, Mahmuda Akter, Lei Sun, Bin Li, Nicole Qian +5 more

The YAP1-MAML2 fusion drives tumorigenesis and sustains tumor growth

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200900

N/A

0DataRank · unranked

3 citations

Yu Mu, Rongqiang Yang, Jennifer W. Li, Xin Zhou, Ozlem Calbay +5 more